Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the EVEREST II Study

Authors: Kelvin Yi Chong Teo, Kyu-Hyung Park, Nor Fariza Ngah, Shih-Jen Chen, Paisan Ruamviboonsuk, Ryusaburo Mori, Nagako Kondo, Won Ki Lee, Rajesh Rajagopalan, Ryo Obata, Ian Y. H. Wong, Caroline Chee, Hiroko Terasaki, Tetsuju Sekiryu, Shih-Chou Chen, Yasuo Yanagi, Shigeru Honda, Timothy Y. Y. Lai, Chui Ming Gemmy Cheung

Source: Ophthalmology and Therapy, Vol 13, Iss 4, Pp 935-954 (2024)

Subject Terms: Polypoidal choroidal vasculopathy, Long-term outcomes, EVEREST II, Anti-vascular endothelial growth factor (VEGF) therapies, BCVA, Ophthalmology, RE1-994

File Description: electronic resource

Relation: https://doaj.org/toc/2193-8245; https://doaj.org/toc/2193-6528

Access URL: https://doaj.org/article/7c0da20fff674871a1afe773e1ed28b1